&Partners’s Astera Labs ALAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$224K Sell
2,050
-1,925
-48% -$274K ﹤0.01% 2177
2025
Q4
$661K Sell
3,975
-20
-0.5% -$3.35K ﹤0.01% 1466
2025
Q3
$783K Buy
3,995
+509
+15% +$83.7K 0.01% 1205
2025
Q2
$313K Buy
+3,486
New +$275K ﹤0.01% 1597
2025
Q1
Sell
-2,332
Closed -$339K 1810
2024
Q4
$339K Buy
+2,332
New +$219K ﹤0.01% 1273

Other funds holding ALAB

&Partners's ALAB Position: Q1 2026 in Review

&Partners reduced its Astera Labs (ALAB) stake by 48% in Q1 2026, selling an estimated $274K and leaving 2,050 shares worth $224K. The position accounts for ﹤0.01% of the portfolio, ranked #2177.

&Partners first reported a position in ALAB in Q4 2024 and has held it in 5 quarters since. The position peaked at $783K in Q3 2025. 703 funds tracked by Wall St. Rank hold ALAB as of Q1 2026.

  • &Partners held 2,050 shares of Astera Labs worth $224K as of Q1 2026.
  • &Partners sold 1,925 Astera Labs shares in Q1 2026, an estimated $274K.
  • Astera Labs made up ﹤0.01% of &Partners's portfolio in Q1 2026, its #2177 holding.
  • &Partners first reported a position in Astera Labs in Q4 2024 and has held it in 5 quarters since.
  • &Partners's Astera Labs position peaked at $783K in Q3 2025.
  • 703 funds tracked by Wall St. Rank held Astera Labs as of Q1 2026.

Based on &Partners's 13F filing for Q1 2026, filed 15 May 2026.